Dr. Eric Donnenfeld performed Long Island’s first iDose TR procedure on August 15, 2024, revolutionizing glaucoma treatment with continuous medication delivery. This achievement underscores OCLI Vision’s leadership in innovative eye care.
GARDEN CITY, N.Y., Sept. 3, 2024 /PRNewswire-PRWeb/ — OCLI Vision is proud to announce a groundbreaking achievement at one of its Long Island locations. Thursday, August 15th, Dr. Eric Donnenfeld, MD, one of the nation’s top ophthalmologists, accomplished a historic milestone by performing Long Island’s very first iDose TR procedure.
Dr.Donnenfeld is a trailblazer in ophthalmology, renowned for his expertise in refractive, cornea, and cataract surgery. His exceptional skill has earned him the title of Newsweek’s top ophthalmologist in the United States for three years running (2021, 2022, 2023). His reputation as a leading authority in eye care is firmly established.
The iDose TR procedure marks a revolutionary leap in treating Open-Angle Glaucoma (OAG) and Ocular Hypertension (OHT). This cutting-edge treatment involves a unique, long-duration, anchored intracameral therapy that continuously delivers prostaglandin analogs directly into the eye’s anterior chamber. This steady medication release ensures superior, long-term control of intraocular pressure (IOP), offering patients a groundbreaking alternative to traditional treatments.
This pioneering procedure not only highlights OCLI Vision’s dedication to incorporating the latest advancements in eye care but also underscores Dr. Donnenfeld’s role in pushing the boundaries of ophthalmologic innovation. The successful execution of iDose TR reinforces OCLI Vision’s reputation as a leader in cutting-edge eye care.
For those eager to learn more about this revolutionary procedure and explore how it might benefit your eye health, please contact OCLI Vision at 833-509-6254 for more information.
About OCLI Vision
Founded in 1997, OCLI Vision (https://www.ocli.net) is one of the leading ophthalmology and optometry practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania, and West Virginia. OCLI Vision is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care, who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.
According to the Lymphatic Education & Research Network, an estimated 1 in every 1,000 people in the United States suffers from lymphedema. Among cancer survivors, the prevalence is higher, with about 20-40% of breast cancer survivors developing lymphedema, particularly post-surgery and radiation therapy. The economic impact of lymphedema includes direct medical costs for treatment and indirect costs such as lost productivity.
Dr. Andrew Elkwood, practicing surgeon and founder of The Institute for Advanced Reconstruction stated, “Dr. Dayan’s arrival marks a significant milestone for patients seeking advanced treatment options for lymphedema, a condition that poses significant challenges for individuals, particularly those undergoing breast cancer treatment. While lifelong compression and physiotherapy have been standard treatment approaches, many patients continue to experience disease progression despite their compliance. Dr. Dayan’s expertise offers hope for those in need of alternative solutions.”
“Joining The Institute for Advanced Reconstruction and establishing The Institute for Lymphatic Surgery and Innovation will offer patients suffering from lymphedema a new option for care that will feature state-of-the-art techniques with use of some of the newest technology and instruments in the world,” said Dr. Dayan. “Our established presence in NJ and partnerships with some of the most well-known reconstructive surgery practices throughout the United States will offer patients new innovative options for care of this prevalent disease.”
In addition to assembling a clinical team of experts in lymphatic surgery, The Institute for Lymphatic Surgery and Innovation purchased a Mitaka microscope, the highest resolution microscope available designed specifically for intricate procedures such as lymphatic surgery, allowing surgeons to visualize and operate on lymphatic vessels with exceptional clarity and precision. Other advanced instruments being used at The Institute include an ultra-high frequency ultrasound and ICG lymphangiography, further enhancing specific care for patients.
Dr. Dayan began seeing patients from around the world and performed the first lymphatic surgery at The Valley Hospital on August 16th. The surgery included immediate lymphatic reconstruction using lymphovenous bypass to reduce the risk of lymphedema at the time of axillary dissection.
Dr. Dayan’s surgical contributions extend to several areas. For breast reconstruction, he utilizes techniques that use the patient’s own tissue, including DIEP, GAP, and PAP flaps. Notably, Dr. Dayan pioneered the DUG flap technique, expanding treatment options for a broader range of patients. Dr. Dayan has extensive microsurgical experience utilizing a range of techniques to reanimate the face due to facial paralysis from conditions like parotid cancer, acoustic neuroma, Bell’s Palsy and developmental facial paralysis. He is an expert in surgical planning that utilizes nerve transfers, grafts and muscle transfers to restore function and quality of life to patients with facial paralysis.
Prior to joining The Institute, Dr. Dayan spent 10 years at Memorial Sloan Kettering Cancer Center, where he established lymphatic surgery and facial nerve programs, and honed his skills through an esteemed fellowship in advanced microsurgical reconstruction at the renowned Chang Gung Memorial Hospital in Taiwan.
Dr. Dayan was honored with the prestigious Godina Traveling Fellowship in recognition of his significant contributions to microsurgery. With over 100 peer-reviewed publications, numerous book chapters, and his recent editorial work on a textbook dedicated to lymphedema, Dr. Dayan continues to advance knowledge and understanding in his areas of expertise. He serves as the founding president of the American Society for Lymphatic Surgery and has been a dedicated board member of the Lymphatic Education and Research Network for over a decade.
Dr. Dayan has been recognized with several prestigious awards, including Castle Connolly’s America’s Top Doctor in 2024, Top Doctor in the New York Metro Area in 2023, and national and regional Top Doctor in New York Magazine from 2016 to 2020.
Dr. Dayan is currently seeing patients in Westwood, NJ. For more information or to schedule a consultation, please visit www.AdvancedReconstruction.com or call 833-598-2417.
About the Institute for Advanced Reconstruction
The Institute specializes in advanced reconstructive surgery and innovative healthcare solutions. Our expert team addresses numerous conditions, ranging from cancer-related diseases and hand trauma to peripheral nerve disorders. Based on an academic, collaborative care approach, we bring together the specialized training and expertise of the country’s finest surgeons and medical teams to deliver transformative results.
With clinics across the country, The Institute attracts patients from around the globe by providing access to the world’s most accomplished doctors, state-of-the-art surgical techniques, and advanced medical technologies. We are dedicated to cutting-edge research and advancing medical frontiers, persistently raising the bar on what is possible in reconstructive healthcare.
“We are excited to partner with CellEx,” said Alain Alonso, vice president of sales at MatTek. “This licensing deal not only signifies our entry into one of the world’s largest and most dynamic markets but also aligns with our mission to innovate and provide superior 3D models globally. We are confident that this collaboration will create significant value for our customers in China.”
MatTek tissues are currently produced in laboratories in the United States and Slovakia and are shipped from those locations worldwide. MatTek’s partnership with CellEx will allow tissues to be produced within China, serving an entirely new market of customers eager to utilize this technology.
“We are so honored to collaborate with MatTek,” said E (Robert) Zhao, chief executive officer of CellEx. “This licensing deal makes up for the huge demand gap of all kinds of customers in the Chinese market for a long time, as well as promoting the integration of Chinese tissue engineering technology with international standards.”
MatTek and CellEx share a commitment to expanding the global reach of lab-grown microtissue technology. The collaboration will provide access to researchers in China and empower them to choose human-relevant research and testing solutions. MatTek and CellEx anticipate that the collaboration will begin to produce human tissues within the next six months, with a series of new product launches and market expansions planned.
Honorees included health care professionals, caregivers, people with PH and PHA support group leaders. See the full list of honorees below.
Julie Hendry Memorial Scholarship Award: Adriana C. Mares
Named for PHA’s first full-time non-patient volunteer, this award supports a non-patient volunteer who advances PHA’s mission. Mares, a student researcher at Yale, received this award for her leadership in the El Paso PHighters support group and her contributions to cardiovascular medicine. She has authored over 25 peer-reviewed journal articles and founded the Institute of Cardiology at El Paso, focusing on PH and congenital heart disease.
The Rino Aldrighetti Leadership Award: Anton Morkin
Recognizes exceptional leadership in advancing PHA’s vision of a world without PH. Morkin was honored for co-founding TBX4Life, a nonprofit supporting people with TBX4 Syndrome and heritable PAH. Motivated by his son’s diagnosis, Morkin’s work has united families from over 10 countries and established a global scientific consortium of more than 70 members. His efforts have driven cross-disciplinary research focused on discovering new treatments.
The PHA Philanthropy Award: Ed and Judith Simpson
Recognizes outstanding charitable commitment and generosity that encourages financial support for PHA. Judy Simpson founded the organization that became PHA in 1991, along with her sister Pat Paton, Teresa Knazik, Dorothy Olson, and their husbands. The Simpsons have been long-standing supporters of PHA, contributing their time, talents and resources since the organization’s inception.
Outstanding Physician: Jean M. Elwing, MD
Recognizes notable service to PHA through clinical care, research, education and advocacy for PH patients. Elwing, director of the pulmonary hypertension program at the University of Cincinnati, received this award for her leadership in pulmonary vascular disease and PH research. She has been an influential figure in advancing clinical care and improving outcomes for those affected by PH.
Outstanding Allied Health Professional: Sandra Lombardi, RN
Recognizes contributions to the PH community through raising awareness, advocacy and compassionate care. Lombardi received this award for dedicating 25 of her 30 years in pulmonary and critical care medicine to pulmonary arterial hypertension. She has educated patients and providers on PAH medications and coordinated clinical trials, all while leading a thriving support group for 25 years, which she considers her proudest achievement.
Outstanding Young PH Citizen Award: Cash Harpp
Honors a person with PH, aged 30 or under, for their dedication to the PH community through awareness, advocacy and service. Harpp has shown remarkable resilience while living with idiopathic PAH. He actively participates in clinical trials and advocates for other children with PH.
Outstanding PH Citizen: Michelle Sweitzer
Recognizes a person with PH for their exemplary dedication to the PH community. Sweitzer has spent more than 40 years advocating and raising awareness, driven by the loss of her brother and father to PH. Through a family-run golf tournament, she has raised over $400,000 for research and remains a passionate advocate following her own PH diagnosis in 2017.
Outstanding Caregiver: Cindy Warnberg
Recognizes a non-patient caregiver’s dedication to improving the quality of life for a loved one with PH. After her daughter Chelsea’s PAH diagnosis, Warnberg acted by organizing the Puttin’ PHore Poots golf tournament. Under her leadership, the event has grown steadily, raising more than $200,000 for PH research and awareness.
Outstanding PHA Support Group Leader Award: Sophia I. Esteves
Recognizes a support group leader who creates a welcoming environment and champions awareness and advocacy. Esteves earned the recognition for her leadership of the San Antonio, Texas, support group. A patient advocate for more than 22 years, Esteves also serves as a spokesperson for Johnson & Johnson’s Breathe In, Speak Out campaign, using her platform to inspire and guide those facing the challenges of PH.
About the Pulmonary Hypertension Association
Headquartered in Washington, D.C., the Pulmonary Hypertension Association is the oldest and largest nonprofit patient association dedicated to the pulmonary hypertension community. Pulmonary hypertension is a rare, chronic and life-threatening condition affecting the lungs for which no cure currently exists. PHA’s mission is to extend and improve the lives of those affected by PH.
To achieve this mission, PHA engages people with PH and their families, caregivers, health care professionals, and researchers worldwide to work together to advocate for the PH community, provide support to patients, caregivers and families, offer up- to-date education and information on PH, improve quality patient care, and fund and promote research. For more information, visit PHAssociation.org or connect with PHA on X/Twitter, Instagram, Facebook and LinkedIn.
Erica Bent of Desert Oasis Healthcare Home Health is honored this month due to her continuous care coordination and resourcefulness
DALLAS, Sept. 3, 2024 /PRNewswire-PRWeb/ — Homecare Homebase SM (HCHB), the leading software provider for home-based care, is happy to name Erica Bent, RN Case Manager at Desert Oasis Healthcare Home Health (HPN), as the September 2024 Gold Standard Award winner.
“Erica is an exceptional manager who consistently manages her caseload, completes same-day documentation and ensures continuity of care,” said Brian Michaelsen, MSW, administrator, operations at Desert Oasis Healthcare. “A PointCare star and valuable peer resource, she provides training on system navigation and supply requisitioning and fully integrates HCHB into her patient care practice.”
The Gold Standard Award celebrates outstanding home-based caregivers who utilize HCHB to deliver exceptional patient care. Nominees are submitted by their agency leaders and meticulously chosen by the HCHB team for their expertise, enthusiasm, and steadfast dedication.
“I’ve been a nurse since 2011 and in Home Health since 2016, using HCHB,” said Erica. “What I love about Home Health is the one-on-one time with patients, allowing for uninterrupted care and education in their comfortable home setting, leading to better health outcomes. I’m honored to receive this award and look forward to continuing to provide thorough care for my patients.”
“Erica exemplifies the qualities we seek in a Gold Standard Award winner,” said Brandy Sparkman-Beierle, chief clinical officer at Homecare Homebase. “Her dedication to her patients, meticulous attention to detail, and unwavering commitment to care coordination make her an invaluable asset to Desert Oasis Healthcare Home Health and the broader home-based care community. Erica’s expertise in Homecare Homebase, coupled with her leadership in training and supporting her peers, showcases her ability to integrate best practices into patient care. She truly embodies the spirit of excellence in home health.” To learn more about these companies, visit hchb.com and mydohc.com.
About Homecare Homebase, LLC Founded by industry veterans in 1999, Homecare HomebaseSM (HCHB) is a Dallas-based software leader empowering exceptional home-based care through hosted, cloud-based technology solutions and administrative services. HCHB’s customized mobile solutions enable real-time, wireless data exchange and communication between field clinicians, physicians and office staff for better care, more accurate reporting and improved revenue cycle management. HCHB’s products and services streamline operations, simplify compliance and boost clinical and financial outcomes for home-based care agencies. Each year, over 200,000 HCHB users serve approximately 800,000 patients daily, resulting in over one hundred million visits. The company is part of the Hearst Health network. For more information, visit http://www.hchb.com or call us toll-free at 1-866-535-HCHB (4242).
About Hearst Health The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Care guidance from Hearst Health reaches the majority of people in the U.S. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG,Homecare Homebase and MHK. Hearst also holds a minority interest in the precision medicine and oncology analytics company Aster Insights. Follow Hearst Health on X @HearstHealth and LinkedIn @Hearst-Health.
About Desert Oasis Healthcare Formed in 1981 as one of the first medical groups in the desert communities of southern California, Desert Oasis Healthcare (DOHC) continues to advance with changes in the healthcare market. DOHC provides primary and immediate care, home health, palliative care, clinical research studies and other services to more than 60,000 members/patients living in the greater Coachella Valley and the Morongo Basin of Riverside and San Bernardino counties. The multidisciplinary and comprehensive care programs of DOHC are committed to educating individuals on preventive health care in their daily lives, reflected in the DOHC motto, “Your Health. Your Life. Our Passion.” For more information, visit http://www.mydohc.com.
The Freedom Titan PCK Revision Knee System maintains the same advanced, clinically proven design as the Freedom PCK Revision Knee System, featuring progressive constraint kinematics, multi-radius femoral design, patented trapezoidal box, and titanium stems, augments and couplers. Titan PCK has a unique golden color on the femoral and tibial components from the titanium niobium nitride (TiNbN) coating produced by a physical vapor deposition (PVD) process. The strong TiNbN coating has been shown to block or significantly reduce the release of metal ions common in orthopedic joint replacement implants.
Titan PCK System demonstrates our ongoing pursuit of knee arthroplasty solutions that address needs in total joint replacement, especially the 10-15% of the population with metal sensitivity. Farzin Khaghani, Chief Commercial Officer, states “The FDA clearance of Freedom Titan PCK System further demonstrates our commitment to developing a strong product pipeline that broadens our portfolio, drives growth, and addresses the needs of a diverse patient population. We are thrilled to offer our distinct Titan knee portfolio to osteoarthritis patients dealing with challenges associated with metal sensitivity.”
Maxx Orthopedics has established a partnership with Unik Orthopedics (UNIKO) to offer personalized surgical instrument blocks for total knee arthroplasty.
UNIKO recently received FDA 510(k) clearance for PointCloud™ Knee Instrument intended for use in surgery to assist with intraoperative implant placement and as a guide for bony resections during total knee replacements. Preoperative MRI scans are obtained during the Pre-Op planning process and used to identify anatomic landmarks necessary for alignment and positioning of the implant during the procedure.
UNIKO PointCloud Knee Instruments (UKI) and the Vault System (web-based surgical planning tool) are compatible with the Freedom® Total Knee System. Combining the UNIKO PointCloud with our Quick Recovery Solutions (QRS®) platform, offers a perfect blend of complementary technologies and an efficient, cost-effective solution for ambulatory surgery centers and hospitals.
The PointCloud Knee Instruments allow surgeons to have patient-specific, CNC machined solid block (Acetal-C), single-use instruments during surgery. Surgeons will be able to precisely template PSI blocks during pre-operative planning and recommend patient-specific component sizing. “Dr. Kurtis Biggs (Naples, FL) recently performed the first Freedom Primary Knee procedure in the United States using the new UNIK Ortho PSI blocks. Our partnership with UNIKO should increase efficiency for total knee arthroplasty within outpatient surgery centers and hospitals. We are excited to offer QRS, Freedom Knee System, and PointCloud technologies together for the benefit of both patients and surgeons, states Anand Bala, Vice President of Product.
References
1. Serro et al. (2009) A Comparative Study of Titanium Nitrides, TiN, TiNbN and TiCN, as Coatings for Biomedical Applications. Surface & Coatings Technology 203 (2009), pp. 3701–3707
About Maxx Orthopedics, Inc.
Maxx Orthopedics, Inc. is the manufacturer of the Freedom Knee System, Libertas Total Hip System, and Quick Recovery Solutions (QRS). We develop and market innovative orthopedic medical devices with a focus on providing state-of-the-art implants and related solutions designed that best restore patient mobility, while accommodating lifestyle, anatomical and economic needs. Find out more at www.maxxortho.com and follow us on LinkedIn, X, Instagram, and Facebook.
As an internist, Dr. Kalva can treat most medical disorders but has special interest in weight loss, cardiovascular health, cardiometabolic/metabolic syndrome, men’s health, integrative primary care, hypothyroidism, fatigue, aging, MTHFR/COMT genetic vulnerabilities, and much more. He has made it his life mission to heal people in a natural, integrative way without prescription drugs whenever possible so that patients can lead positive and active lives.
Dr. Kalva is accepting new patients. He is committed to providing care for the whole person by using innovative functional medicine services to help patients achieve a better level of health.
About National Integrated Health Associates
National Integrated Health Associates, NIHA, is a leading integrative and functional medicine and holistic dental center serving the Washington D.C., Maryland, and Virginia metropolitan area. Practitioners blend the best of conventional medicine and integrative medical therapies to help the body heal and achieve optimum wellness. Specialty lab and IV services, chiropractic care and detoxification therapies are offered on-site at our convenient integrative health center in Washington, D.C.https://nihadc.com
“We are excited to launch Ask Monica as a fresh way to provide our patients and the community with access to reliable and concise answers about fertility,” said Dr. Mark Leondires, founder and medical director of Illume Fertility. “With more than 20 years of experience in reproductive healthcare, Monica’s expertise has made her a trusted source of information for anyone facing fertility challenges.”
New episodes of Ask Monica will be released monthly and will cover a wide range of topics, including:
Causes of infertility
Fertility treatment options like IUI and IVF
How to optimize diet and lifestyle while trying to conceive
Pregnancy after infertility
Polycystic ovary syndrome (PCOS)
“I am passionate about helping people achieve their goals, whether they are trying to conceive, manage conditions like polycystic ovary syndrome (PCOS), or find ways to improve their overall health,” said Monica Moore, Nurse Practitioner at Illume Fertility. “My hope is that Ask Monica will provide viewers with the knowledge and support they need to navigate their personal journey.”
About Illume Fertility Illume Fertility is a leading modern fertility practice providing an exceptional patient experience, innovative care, and expertise to help patients achieve their fertility and family-building goals. Led by an award-winning team of nine highly credentialed, board-certified reproductive endocrinologists, many of whom have received Castle Connolly’s prestigious Top Doc award, Illume Fertility specializes in a range of assisted reproductive technologies (ART) including intrauterine insemination (IUI), in vitro fertilization (IVF), and preimplantation genetic testing (PGT). Illume Fertility’s internationally recognized Gay Parents To Be resource hub provides specialized support for LGBTQ+ family building. For the last seven years, Illume Fertility has been recognized as a Leader in Healthcare Equality by the Human Rights Campaign. Illume Fertility is one of the largest fertility clinics and egg donation centers in the region, offering egg freezing, oncofertility preservation, and PCOS management, helping patients as young as 16. Illume Fertility is the only regional fertility clinic offering on-site holistic patient support services including nutrition counseling, acupuncture, and yoga.
“It is vital to spread awareness about how vestibular dysfunction can dramatically impact one’s life, and provide hope to people struggling with these symptoms,” said Cynthia Ryan, Executive Director of VeDA. “Even though these may be chronic conditions, there are treatments and coping strategies that can help you regain function and improve your quality of life.”
“Losing balance can feel like losing control of your body,” says Darcy Bonjour, a vestibular patient and VeDA Board Member. “It can be scary and overwhelming. When I started my vestibular journey in 2005, I can still remember how I felt the first time I walked in public. I was so unsteady I had to hold onto my husband to stay upright.”
“Until I lost my balance, I took my vestibular system for granted,” says Jennifer Crespo. “Then, when I was 36 weeks pregnant, my life literally turned upside down. I went from having complete balance to losing it in a matter of seconds. This led to developing a chronic disorder that has persisted for years.”
Darcy and Jennifer are among the many VeDA Ambassadors who have transformed their painful experiences into a force for good. They strive to lessen the stigma related to chronic vestibular dysfunction and inspire people to seek the care and support they need.
To learn more about Balance Awareness Week and how you can get involved visit:
ABOUT the Vestibular Disorders Association / (VeDA)
VeDA supports people with dizziness, vertigo, and imbalance by connecting them with qualified vestibular healthcare specialists and peer support networks. VeDA advocates for improvements to the medical system that will shorten the diagnostic journey and improve patient outcomes.
During Healthy Aging Month, Kyowa Hakko USA encourages everyone to learn the role that its nootropic Cognizin® plays in brain health and healthy aging.
NEW YORK, Sept. 3, 2024 /PRNewswire-PRWeb/ — Kyowa Hakko USA, an international health ingredients manufacturer, is launching an educational campaign for Cognizin®, their leading brain health ingredient. Formulated clinically to support mental energy, focus, and attention*, Cognizin® is featured in various delivery systems available in over 200 products to support brain health and healthy aging.
Due to its proven efficacy and versatility, brands have been increasingly turning to Cognizin®, looking for the long-term brain health benefits that Cognizin® offers when taken daily. Its vegetarian and allergen-free formulation makes it accessible to a wide range of people. Unlike artificial stimulants, which can cause significant crashes, Cognizin® provides cognitive support.
“At Kyowa Hakko, we recognize the importance of cognitive health across all life stages, and with the pivotal role brain health plays in daily activities, we are advocating for proactive measures to support brain health and enhance quality of life,” said Karen E. Todd, RD, CSCS, EP-C, CISSN, and Vice President of Global Marketing of Kyowa Hakko USA. Todd added: “In today’s fast-paced world, maintaining optimal cognitive function is crucial for everyone, and one way to do it is by choosing supplements that include Cognizin® to help you live your best life with optimized brain health.”
With cognitive function influencing every aspect of our lives, from the ability to perform daily tasks to our capacity to learn and have emotional responses, Cognizin® citicoline has great potential to promote healthy brain aging. A vast number of studies conducted around this have explored the benefits of citicoline, which naturally occurs in every cell of the body as a supplement, that helps better understand this nutrient and how it supports cognitive health and performance.
This September, in celebration of Healthy Aging Month, Cognizin® will be launching “Your Brain Health, Your Way” educational campaign with Jamie Hess, an influential media personality and wellness expert, who has partnered with Cognizin® to promote this leading brain health ingredient to her Gratitudeology™ Podcast audience. “I’m thrilled to partner with Cognizin® to not only bring this critical information to consumers, but to highlight the amazing number of products – over 200 – currently on the market. From protein bars and smart chocolates to energy stick packs and gummies, as well as beverages and fortified water,” commented Hess.
As a global leader in health ingredients manufacturing, Kyowa Hakko utilizes extensive research to create innovative solutions with its comprehensive portfolio of well-researched branded ingredients, such as Cognizin®, which meets the most demanding U.S. dietary supplement industry standards. Kyowa Hakko USA represents Kyowa Hakko Bio Co. Ltd.’s mission to provide life-supporting products that contribute to the health and well-being of people around the world.
About Cognizin® Citicoline: Cognizin® Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and branded form of Citicoline, a natural substance made endogenously in the body and especially vital to brain health. Citicoline is a potent brain-health nutrient. A proprietary form of citicoline, Cognizin® has been clinically studied to support mental energy, focus, attention, and recall. Cognizin® is manufactured through a fermentation process to yield high quality and high purity. Cognizin® is also highly stable, GRAS, ultra-pure, and allergen-free. For more information on Cognizin®, visit Cognizin.com.
About Kyowa Hakko USA: Kyowa Hakko USA is the North & South American office of Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals, and food & beverage products. Kyowa is the maker of branded ingredients, including IMMUSE™ LC-Plasma, Eyemuse™ Lacticaseibacillus paracasei KW3110, Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as L-Alanyl-L-Glutamine. For more information, visit http://www.kyowa-usa.com/.
